Our findings show an increase in cHL tissue predominantly in patients with nodular sclerosis and a significant increase in plasma, congruent with previous studies [53] of CCL17 in cHL, supporting the central role of CCL17 in the pathophysiology of cHL. The gene discussed is CCL17; the disease is classic Hodgkin lymphoma.